United Therapeutics | UTHR - Trade Creditors


United Therapeutics reported $468M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Amarin USD 36.71M 8M Sep/2025
Ardelyx USD 18.39M 3.29M Sep/2025
Baxter International USD 999M 46M Dec/2025
Bayer EUR 6.38B 343M Sep/2025
BioCryst Pharmaceuticals USD 5.57M 3.02M Sep/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Emergent BioSolutions USD 112.2M 500K Dec/2023
Esperion Therapeutics USD 77.51M 2.81M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Insmed USD 79.91M 316K Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
J&J USD 11.99B 2.37B Dec/2025
Lexicon Pharmaceuticals USD 5.9M 4.79M Jun/2025
Moderna USD 317M 50M Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Pfizer USD 5.02B 142M Sep/2025
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
Teva Pharmaceutical Industries USD 2.53B 176M Dec/2025
United Therapeutics USD 468M 36M Sep/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025